Dr. Esrailian is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
200 Medical Plz
# 365
Los Angeles, CA 90095Phone+1 310-794-9718Fax+1 310-794-1787
Summary
- Dr. Esrailian attended the University of California at Berkeley and graduated with a major in integrative biology and a minor in English. He subsequently graduated from the Loma Linda University School of Medicine and completed a residency in internal medicine at the University of Southern California.
He completed his gastroenterology fellowship at UCLA where he also obtained a masters of public health degree with the assistance of an NIH sponsored training grant. He is also a graduate of the Executive Program in Management from the UCLA Anderson School of Management. Dr. Esrailian served on the Medical Board of California from 2010-2011 after being appointed by Governor Arnold Schwarzenegger.
Dr. Esrailian's primary clinical interests include gastrointestinal endoscopy, inflammatory bowel diseases, gastrointestinal hemorrhage, and functional gastrointestinal diseases such as irritable bowel syndrome. In addition to disease areas within gastroenterology and internal medicine, Dr. Esrailian has a particular interest in the development of biomedical innovations, value in health care, medical education, initiatives towards patient-centered care, and connections between health and human rights.
In 2012, the School of Medicine awarded him the Lincy Foundation Chair in Clinical Gastroenterology. He is closely involved in growth strategy and strategic planning efforts for the UCLA Health System and the David Geffen School of Medicine at UCLA. He also works to facilitate community engagement with a number of other schools and departments within the UCLA campus and its Los Angeles community partners, and he is on the UCLA campus steering committee for the Centennial Campaign. Dr. Esrailian was named the 43rd Annual Lester Breslow Distinguished Scholar and Lecturer by the UCLA Fielding School of Public Health. In 2017, the university designated Dr. Esrailian as a UCLA Optimist -- among its notable alumni and faculty dedicated to solving the world’s problems.
Education & Training
- UCLA David Geffen School of Medicine/UCLA Medical CenterFellowship, Gastroenterology, 2003 - 2006
- University of Southern California/Los Angeles General Medical Center (USC/LA General)Residency, Internal Medicine, 2000 - 2003
- Loma Linda University School of MedicineClass of 2000
Certifications & Licensure
- CA State Medical License 2002 - 2025
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Gastroenterology
Awards, Honors, & Recognition
- Regional Top Doctor Castle Connolly, 2014
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2013
- Lincy Foundation Chair in Clinical Gastroenterology David Geffen School of Medicine at UCLA
Publications & Presentations
PubMed
- 119 citationsOctreotide/Midodrine Therapy Significantly Improves Renal Function and 30-Day Survival in Patients with Type 1 Hepatorenal SyndromeEric Esrailian, Eugene R. Pantangco, Namgyal L. Kyulo, Ke-Qin Hu, Bruce A. Runyon
Digestive Diseases and Sciences. 2007-01-19 - 48 citationsDevelopment and Validation of an Inflammatory Bowel Diseases Monitoring Index for Use With Mobile Health TechnologiesWelmoed K. van Deen, Andrea E. van der Meulen-de Jong, Nimisha K. Parekh, Ellen Kane, Aria Zand
Clinical Gastroenterology and Hepatology. 2016-12-01 - 19 citationsNoninvasive Colorectal Cancer Screening Tests Help Close Screening Gaps During Coronavirus Disease 2019 Pandemic.Anthony Myint, Lily Roh, Liu Yang, Lynn S. Connolly, Eric Esrailian
Gastroenterology. 2021-04-16
Press Mentions
- Billionaire Surgeon Donates $120M to UCLAAugust 28th, 2024
- UCLA Health Walks Community Through Risks, Symptoms of Colorectal CancerMarch 12th, 2023
- Los Angeles Area Bioscience Academic Institutions, Researchers, Industry and Investors Converge at LABEST May 25 – 27, 2021May 10th, 2021
- Join now to see all
Professional Memberships
- Member
- Member
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: